Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Morten Mau-Sørensen, Scott Randall Plotkin, Patrick Y. Wen, Andrew L. Kung, Ulrik Niels Lassen, Jean-Richard Saint-Martin, Greg Wright, Aleksander Chudnovsky, Joel Ellis, Sharon Friedlander, Bert van Eijk, Sharon Shacham, Michael G. Kauffman et al | ||||||||||||
Title | A phase 2 study on efficacy, safety and intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM). | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/176/AbstView_176_170208.html | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2077) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|